North Bergen, New Jersey — September 17, 2025 — Leads & Copy — Apollo Biowellness, Inc. (OTCID: KOAN) has announced it has signed a Letter of Intent with Revive Regenerative, Inc. to pursue a potential merger.
The merger is to be a 60/40 transaction with Revive shareholders receiving 60% and Apollo shareholders and debt holders receiving 40% of the combined company, subject to the terms and conditions set forth in the definitive merger agreement. The surviving company will be Revive Regenerative, Inc., and the Company will become a wholly owned subsidiary of Revive.
Revive will be a publicly traded holding company having two wholly owned subsidiaries, that being Revive Lasers, Inc. and Revive Biologics, Inc. Revive Biologics, Inc. will oversee and manage all the operations and production of Evolutionary Biologics, Inc.
Upon closing, James Palastra will assume the position of CEO of the holding company.
James W. Zimbler, President and CEO, stated, “I am thrilled to announce this milestone for the Company and to become part of Revive Regenerative and its seasoned professionals-from the executive team to the commercial organization. The combination of the Evolutionary Biologics product line and the Revive laser products will take the Company to a level we have only dreamed about.”
James Palastra, stated, “Today marks an exciting milestone for the customers, employees, partners, and shareholders of both Apollo Biowellness and Revive Regenerative. By uniting our organizations, we are creating a powerful platform that combines advanced energy-based devices with a comprehensive line of regenerative biologic solutions. Together, we will deliver more effective, integrated offerings that empower practitioners to achieve better outcomes for their patients.”
Contact
James W. Zimbler
President/CEO/Director
info@evolutionarybiologics.com
631-806-1420
Source: Apollo Biowellness, Inc.
